Quantum Si Inc (QSI) Cotización

Lambchops in this position now. QSI in ARK portfolio. they have good feel for up and coming companies.Good luck to all.

LC

QSI

HOWS THAT BULLISH REVERSAL PATTEERN,,,LOL...CANDLE STICK FAKE CLOWN

QSI...$1.30...🥳...Scaling in on this ..Bullish Deliberation Reversal Pattern... https://schrts.co/yWqxRGqu ...https://www.businesswire.com/news/home/20241205446158/en/

JUST A TRADE AND EXIT INTO YESTERDAY PRE MARKET PUSH

What changed for you to be back on board

QSI..........................https://stockcharts.com/h-sc/ui?s=QSI&p=W&b=5&g=0&id=p86431144783

QSI 3 BUCKS CLOSING IN

Can’t win them all. Hope you jumped in

QSI HERE COMES 3.00

super smart people put their own money at risk ---- often times i follow them

QSI READY FOR 3 BUCKS

QSI EXPLOSION COMING IN HERE

Quantum-Si price target raised to $5.50 from $4 at H.C. Wainwright

November 21, 2024 — 06:17 am EST

H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Quantum-Si (QSI) to $5.50 from $4 and keeps a Buy rating on the shares. The company hosted an investor day to unveil its new and enhanced protein sequencing technology as well as discuss its go-to-market strategy, the analyst tells investors in a research note. The firm says Quantum-Si’s new sequencing platform “could be a game-changer.” Proteus could help to significantly deepen and broaden market penetration beyond academic institutions to government and pharma sectors, who may be able to utilize the technology for applications, such as translational medicine, drug discovery, and diagnostics, contends H.C. Wainwright.

https://www.nasdaq.com/articles/quantum-si-price-target-raised-550-4-hc-wainwright

$QSI

QSI.................................https://stockcharts.com/h-sc/ui?s=QSI&p=W&b=5&g=0&id=p86431144783

Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™

December 04, 2024

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has introduced the Platinum Library Prep Kit, V2, an advanced tool for single-molecule protein sequencing that is designed to simplify workflows and expand researchers’ ability to analyze the proteome.

The new kit is designed to deliver significant advancements in accessibility and efficiency, offering researchers a streamlined library preparation process that reduces hands-on time to under two hours while maintaining precision and reliability.

Key features include:

• Improved Performance: 85% of proteins attempted generated successful libraries and sequencing results, expanding protein diversity for deeper proteomic studies

• Enhanced Workflow: Optimized for a variety of protein conditions, using fivefold less protein input than V1 making it ideal for limited or precious samples

• Simplified Preparation: Produces sequencing-ready libraries using standard lab equipment with less than two hours of hands-on time

“Our new Library Prep Kit sets the standard for accessibility in proteomics, making Next-Gen Protein Sequencing™ even more accessible and achievable for any research lab with our benchtop instrument,” said Jeff Hawkins, President and Chief Executive Officer. “This innovation will help empower researchers to unlock deeper insights into the proteome with ease, driving breakthroughs that bring us closer to understanding the complexity of life at the molecular level.”

For more information about Quantum-Si’s innovative solutions, visit www.quantum-si.com.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://ih.advfn.com/stock-market/NASDAQ/quantum-si-QSI/stock-news/95035955/quantum-si-launches-platinum-new-library-prep-kit

$QSI

Did I miss something to make it “not a great play”. Thanks and appreciate the view from another lens.

Why?

NOT A GREAT PLAY

come GREEN soon ?

pre now Red ( - 2.5 %)

wow that's great and fantastic - with NVIDIA

I'm holding some.

================

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

November 21, 2024

Provides Update on the Company’s Innovation Roadmap & New Development Partnerships

Highlights new Distribution Agreement with Avantor in the U.S. and Canada

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024.

Quantum-Si’s Management team announced Platinum™ Pro, the Company’s evolution of Platinum, as well as Proteus™, the Company’s new cutting-edge proteomics platform of the future, that is now under development.

“We are very excited to have this opportunity to unveil the rapid innovation that we have achieved at Quantum-Si over the last 15 months since our R&D realignment process last August,” said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si. “First, the launch of Platinum Pro will provide meaningful enhancements over our current Platinum platform in relation to workflow, applications and onboard software analysis.”

Hawkins continued, “Second and most important, we believe the development and launch of our Proteus platform is set to redefine proteomics with unprecedented output per sample, application flexibility and automation. We believe Proteus is the foundational platform to enable billions of sequencing reads and eventually de novo sequencing of the proteome. Finally, with this innovation path, we also believe Proteus and future related innovations will open broad new markets for diverse applications in protein analysis, driving increased revenue growth that will create significant value for our shareholders. With these technology advancements and partnerships in place, we believe we will be able to further extend our leadership position in next-generation protein sequencing while also extending into other areas of proteomics more generally.”

Platinum Pro: Exciting Progress of Enhanced Protein Sequencing
The Company announced a next-generation Platinum system, the Platinum Pro, which is scheduled to launch in the first half of 2025. Platinum Pro will provide a streamlined workflow, reducing hands-on time, and faster processing time. Platinum Pro will enable data analysis to be performed locally or using the cloud and will also offer a ‘Pro Mode’, which allows for custom application development, a compelling feature for biopharmaceutical customers.

Proteus: The Proteomics Platform of the Future
The Company also announced the development of a new cutting-edge proteomics platform, Proteus, which is scheduled to launch in the second half of 2026. Proteus will enable a broad range of capabilities for proteomic analysis including ultrasensitive detection of proteoforms, unbiased interrogation of high complexity samples, and new rapid sequencing chemistry that can reduce the run time per sample to 90 minutes or less. The new Proteus platform will also include automated liquid handling to reduce hands-on time and increase sample throughput.

The Company expects that Proteus will be the foundational platform to increase the output of sequencing reads from tens of millions of reads per sample at launch to billions of reads per sample over time. Further, the Company anticipates that Proteus, combined with other technology development initiatives, will enable de novo sequencing in the future.

Proteus represents a significant transformation to the Company’s core technology architecture, moving the optics into the instrument and allowing the Company to make a low cost, scalable consumable and eliminating the higher cost semi-conductor chip technology, dramatically increasing the consumable margin profile for the future.

Most of the Proteus design and planned capabilities leverage existing proven technologies already in place at the Company, including consumable surface chemistry, sequencing chemistry, recognition technology and optical technology; all of which significantly de-risks the development timeline.

New Partnerships
In connection with the development of Proteus, the Company has announced new partnerships and collaborations to accelerate and further de-risk the development and hardware platform delivery process as well a new partnership for commercial execution in North America.

Avantor: The Company announced it has entered into an agreement with Avantor® to distribute the Company’s proteomics solutions in the U.S. and Canada using Avantor’s expert support of its bioMarke team at Avantor. The agreement enables Avantor to offer Quantum-Si’s protein sequencing technology to a broad range of laboratories focused on proteomics. (See related press release).

NVIDIA: The Company has entered into a collaboration with NVIDIA to significantly enhance data processing speeds to handle the increased data volume from Proteus by leveraging NVIDIA’s accelerated computing. With this collaboration and other development milestones, the Company expects processing time to be reduced to 90 minutes. (See related press release).

SkyWater: The Company announced an expanded partnership with SkyWater Technologies for development of Proteus’ consumable platform to increase the output per sample to unprecedented levels. (See related press release).

Planet Innovation: The Company has partnered with Planet Innovation on the development and manufacturing of Proteus. Planet Innovation has a team of over four hundred people with expertise across design, development and manufacturing of scientific instrumentation and medical devices and has a proven track record of rapid development and on time product delivery. Partnering with Planet Innovation will allow the Company to further de-risk development of key components of Proteus on the path to delivery to the market in the second half of 2026. (See related press release).

Webcast Replay
A replay of the Investor & Analyst Day event is available through the Investor Relations section of Quantum-Si’s website at https://ir.quantum-si.com/. The archived webcast will be available for at least 90 days.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://ih.advfn.com/stock-market/NASDAQ/quantum-si-QSI/stock-news/94962752/quantum-si-highlights-major-technical-advances-ne

https://player.vimeo.com/video/905720847?h=3ecca399d9&title=0&byline=0&portrait=0&badge=0&autopause=0&player_id=0&app_id=58479

$QSI

I'm out again, I would never have thought that this stock would be red for 4 days in a row

(incredibly stupid with this good $QSI news / the stupid shorts are winning) and

I would have thought that there would be a nice $QSI recovery above $2, I would never have thought that this stock - of all quantum stocks - performed the worst

the best thing is - all quantum stocks are rising and going higher and higher and this $QSI stock has made the best deal (had great news and the $QSI news is really fantastic and is perhaps the best) and this stock has been falling since = LOL

I'm out


$QSI also has a fantastic structure and should actually rise to $2 to $3 to $4 to $5 but what is this stock doing ?

it's not rising like all the other quantum stocks = that doesn't make sense to me


I can't understand it and I got out and you should rather buy stocks that nobody wants and that don't have any good news - lol

imho

$QBTS A very good Quantum share that has fought its way from -11% into the green and why doesn't $QSI follow suit = $QSI should finally start to rise, nothing has happened for three days, although $QSI is also in the quantum range ?

time to moving up

bounce time now

QSI HOLD INTO OPEN

QSI BIG GAPPA

QSI 2.01 TRIGGER SENDS THIS TO 2.33

QSI GET READY TO ROCK MONDAY..1.25 SUPPORT CAME IN

Yes. Crushed it at Yale!

Jonathan Rothbaum... very smart man

QSI: Second 'SCALP' routine looming!!! (Take a tip from our 'Native American' brothers --- which can be applied to Wall Street too!!!)

QSI: Institutional Ownership 48.13%

Active Positions | Holders | Shares
Increased Positions | 44 | 8,095,138
Decreased Positions | 44 | 2,903,668
Held Positions | 32 | 48,087,303
Total Institutional Shares | 120 | 59,086,109

https://www.nasdaq.com/market-activity/stocks/qsi/institutional-holdings

$QSI

QSI: Sits at the TOP of both of the following (very influential) soaring-stocks LISTS (ignore that one at top of the BARCHART list):
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
https://eresearch.fidelity.com/eresearch/goto/landing.jhtml

Load zone

I have a low bid in, in case I get lucky.
Then, I'll be late and lucky!

QSI: MANY (distinct) news items today!! (See below, if ya have not already read them.)
https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html
https://finance.yahoo.com/news/avantor-distribute-quantum-si-next-123000544.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

Halted like said

Boom 🤩 That's a nice green candle! 💹

=================

Other news today:

Quantum-Si and Planet Innovation to Partner on Proteus™

Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si's novel proteomics platform, Proteus™.

Planet Innovation has a team of over four hundred people with expertise across design, development and manufacturing of scientific instrumentation and medical devices. Currently, Planet Innovation serves as the contract manufacturer for Quantum-Si's Platinum® Pro instrument, set to debut in the first half of 2025. Through this expanded partnership, Planet Innovation will support the development of Quantum-Si's Proteus instrument and serve as the contract manufacturing partner to ensure a seamless transition from development into commercialization.

"We are thrilled to expand our partnership with Planet Innovation and leverage their global scale and expertise to accelerate the development and commercialization of Proteus," said Jeff Hawkins, President and CEO of Quantum-Si. "We believe that partnering with Planet Innovation will allow us to deliver this novel instrument to the market on a timeline of under two years."

"Planet Innovation is proud to support Quantum-Si in developing their new proteomics platform. We have a large, established team with a proven track record in developing world-first life science platforms that are disruptive, compliant and commercialized in record time. We are excited to work side-by-side with the Quantum-Si team in making proteomics more accessible to researchers, scientists and clinicians to ultimately improve human health," said Stuart Elliott, CEO and co-founder of Planet Innovation.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://www.tmcnet.com/usubmit/2024/11/20/10109022.htm

https://planetinnovation.com/

=================

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform

Business Wire
Wed, November 20, 2024

Sets stage for advanced scientific discovery of new diagnostic biomarkers and treatments for disease

BRANFORD, Conn. & BLOOMINGTON, Minn., November 20, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si’s next-generation platform designed to transform proteomic research. The expanded collaboration will develop the consumable for Proteus that will enable simultaneous large factor, protein sequencing with unparalleled accuracy.

Quantum-Si and SkyWater began partnering in 2021 on the first-generation Platinum® platform and announced transition to support production in the second quarter of 2024. SkyWater will continue to supply the consumables for the Platinum Pro product as the two companies expand their engagement to support commercialization of Proteus.

This cutting-edge solution is set to redefine proteomics with unprecedented output per sample, application flexibility and automation. By combining Quantum-Si’s expertise in biotechnology with SkyWater’s Technology as a Service (TaaS) manufacturing capabilities, the collaboration is poised to drive significant advancements in protein sequencing and to the field of proteomics.

"We’re pleased to build on past success together and move into this next product development program with momentum to drive the innovations for this revolutionary proteomics platform," said Ross Miller, SVP Commercial and A&D Business, SkyWater Technology. "This collaboration underscores SkyWater’s commitment to enabling transformative technologies that have the potential to reshape industries and improve lives."

"We are excited to expand our relationship with SkyWater around Platinum, and to apply the learnings and their unique capabilities to our next platform innovation," said Jeff Hawkins, President and CEO of Quantum-Si. "SkyWater’s manufacturing expertise and commitment to innovation make them an ideal partner as we work to commercialize this game-changing platform. With Platinum, we were the first to bring Next-Generation Protein Sequencing™ to researchers globally and we believe our new technology will enable us to further extend our leadership position in protein sequencing and allow us to extend our technology into other areas of proteomics."

Leveraging its custom process development and robust manufacturing capabilities, SkyWater enables the unique technological needs of microfluidic biomedical devices from proof of concept to final qualification. Embracing a TaaS model, SkyWater facilitates early collaboration with system engineers and device designers, developing technology within a production environment. This approach expedites time-to-market, ensures quality from inception, and seamlessly scales to meet volume production demands.

SkyWater holds certification to the ISO 13485 Quality Standard for Medical Devices, affirming its ability to support the design, development, and fabrication of biomedical applications.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

https://www.skywatertechnology.com/

$QSI

Halted up ! Yahoo!!

Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA

Business Wire
Wed, November 20, 2024

Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing™ and Accelerated Data Processing

BRANFORD, Conn., November 20, 2024--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing.

This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leveraging NVIDIA accelerated computing and Quantum-Si’s advanced single-molecule protein sequencing and detection technologies, the collaboration aims to develop a robust data processing system. This system will keep pace with Quantum-Si’s rapidly evolving technology advancements, generating single-molecule protein insights to deepen our understanding of the proteome and develop innovative solutions through research, drug discovery, and healthcare AI.

"We are thrilled to collaborate with NVIDIA to make single-molecule proteomics more accessible to researchers," said John Vieceli, Ph.D., Chief Product Officer of Quantum-Si. We have been leveraging AI protein structure prediction tools with NVIDIA BioNeMo, both in the cloud and on-premises to design new and improved biomolecules. Now, we are excited to apply NVIDIA technology for downstream data processing and interpretation applications for Proteus.

"Sequencing proteins to derive insights requires advanced processing capabilities that can handle vast volumes of data," said George Vacek, Global Head of Genomics Alliances at NVIDIA. "Applying NVIDIA technology for accelerated computing and AI, Quantum-Si’s platform for proteomics and multi-omics can make a significant impact on healthcare and life sciences AI and research."

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html

$QSI

Gonna go parabolic and halt

Agree. I have sells at 2.19

QSI: See ME, below, celebratin' already, Peeps!!! (This QSI little puppy gonna end-up today a MECA-GODZILLA-CLASS MONSTER of Wall Street!!!)

///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

Between $1.45- $2.27 has to do a lot of churn next wide zone. All is possible but going to need a lot of volume 
$1.53 + 141%

QSI: I'll take those profits at circa $10-per-share today, Homeboy!!! (O.K., so I just went totally BONKERS!!! Indeed, see me below, live right now!!!)

$1.40 + 120% take profits boom
Boom

QSI: Check-out their NEWS!!!! Are they KIDDING us????
https://finance.yahoo.com/news/quantum-si-develop-acceleration-platform-120000059.html
https://finance.yahoo.com/news/avantor-distribute-quantum-si-next-123000544.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html
https://finance.yahoo.com/news/quantum-si-expands-collaboration-skywater-113000868.html

Bang bang proteins up above $1.45 resistance 
$1.20s + 90%